id paper:paper_09476539_v23_n45_p10832_Sun
record_format dspace
spelling paper:paper_09476539_v23_n45_p10832_Sun2023-06-08T15:54:00Z Photoactivation of Anticancer Ru Complexes in Deep Tissue: How Deep Can We Go? anticancer metallodrug photochemistry phototherapy ru complex Photochemical reactions Ruthenium Ruthenium compounds Synthesis (chemical) Absorption wavelengths Anti-cancer therapeutics Anticancer Metallodrug Photo activations Photoactivatable Phototherapy Ru complexes Tissue antineoplastic agent coordination compound ruthenium cell survival chemistry drug effects HeLa cell line human infrared radiation spectrophotometry Antineoplastic Agents Cell Survival Coordination Complexes HeLa Cells Humans Infrared Rays Ruthenium Spectrophotometry Activation of anticancer therapeutics such as ruthenium (Ru) complexes is currently a topic of intense investigation. The success of phototherapy relies on photoactivation of therapeutics after the light passes through skin and tissue. In this paper, the photoactivation of anticancer Ru complexes with 671-nm red light through tissue of different thicknesses was studied. Four photoactivatable Ru complexes with different absorption wavelengths were synthesized. Two of them (Ru3 and Ru4) were responsive to wavelengths in the “therapeutic window” (650–900 nm) and could be activated using 671-nm red light after passing through tissue up to 16-mm-thick. The other two (Ru1 and Ru2) could not be activated using red light. Additionally, activated Ru4 caused inhibition of cancer cells. These results suggest that photoactivatable Ru complexes are promising for applications in deep-tissue phototherapy. © 2017 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim 2017 https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_09476539_v23_n45_p10832_Sun http://hdl.handle.net/20.500.12110/paper_09476539_v23_n45_p10832_Sun
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic anticancer
metallodrug
photochemistry
phototherapy
ru complex
Photochemical reactions
Ruthenium
Ruthenium compounds
Synthesis (chemical)
Absorption wavelengths
Anti-cancer therapeutics
Anticancer
Metallodrug
Photo activations
Photoactivatable
Phototherapy
Ru complexes
Tissue
antineoplastic agent
coordination compound
ruthenium
cell survival
chemistry
drug effects
HeLa cell line
human
infrared radiation
spectrophotometry
Antineoplastic Agents
Cell Survival
Coordination Complexes
HeLa Cells
Humans
Infrared Rays
Ruthenium
Spectrophotometry
spellingShingle anticancer
metallodrug
photochemistry
phototherapy
ru complex
Photochemical reactions
Ruthenium
Ruthenium compounds
Synthesis (chemical)
Absorption wavelengths
Anti-cancer therapeutics
Anticancer
Metallodrug
Photo activations
Photoactivatable
Phototherapy
Ru complexes
Tissue
antineoplastic agent
coordination compound
ruthenium
cell survival
chemistry
drug effects
HeLa cell line
human
infrared radiation
spectrophotometry
Antineoplastic Agents
Cell Survival
Coordination Complexes
HeLa Cells
Humans
Infrared Rays
Ruthenium
Spectrophotometry
Photoactivation of Anticancer Ru Complexes in Deep Tissue: How Deep Can We Go?
topic_facet anticancer
metallodrug
photochemistry
phototherapy
ru complex
Photochemical reactions
Ruthenium
Ruthenium compounds
Synthesis (chemical)
Absorption wavelengths
Anti-cancer therapeutics
Anticancer
Metallodrug
Photo activations
Photoactivatable
Phototherapy
Ru complexes
Tissue
antineoplastic agent
coordination compound
ruthenium
cell survival
chemistry
drug effects
HeLa cell line
human
infrared radiation
spectrophotometry
Antineoplastic Agents
Cell Survival
Coordination Complexes
HeLa Cells
Humans
Infrared Rays
Ruthenium
Spectrophotometry
description Activation of anticancer therapeutics such as ruthenium (Ru) complexes is currently a topic of intense investigation. The success of phototherapy relies on photoactivation of therapeutics after the light passes through skin and tissue. In this paper, the photoactivation of anticancer Ru complexes with 671-nm red light through tissue of different thicknesses was studied. Four photoactivatable Ru complexes with different absorption wavelengths were synthesized. Two of them (Ru3 and Ru4) were responsive to wavelengths in the “therapeutic window” (650–900 nm) and could be activated using 671-nm red light after passing through tissue up to 16-mm-thick. The other two (Ru1 and Ru2) could not be activated using red light. Additionally, activated Ru4 caused inhibition of cancer cells. These results suggest that photoactivatable Ru complexes are promising for applications in deep-tissue phototherapy. © 2017 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
title Photoactivation of Anticancer Ru Complexes in Deep Tissue: How Deep Can We Go?
title_short Photoactivation of Anticancer Ru Complexes in Deep Tissue: How Deep Can We Go?
title_full Photoactivation of Anticancer Ru Complexes in Deep Tissue: How Deep Can We Go?
title_fullStr Photoactivation of Anticancer Ru Complexes in Deep Tissue: How Deep Can We Go?
title_full_unstemmed Photoactivation of Anticancer Ru Complexes in Deep Tissue: How Deep Can We Go?
title_sort photoactivation of anticancer ru complexes in deep tissue: how deep can we go?
publishDate 2017
url https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_09476539_v23_n45_p10832_Sun
http://hdl.handle.net/20.500.12110/paper_09476539_v23_n45_p10832_Sun
_version_ 1768545607812644864